Article

Janet Freeman-Daily on Why Patients Should Attend the ASCO Meeting

Janet Freeman-Daily on why patients should attend the annual meeting of the American Society of Clinical Oncology (ASCO).

We spoke with Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago. Here, Freeman-Daily discusses why patients should attend the meeting.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Image of woman with brown hair.
Image of man with black hair.
Image of bald man.
Image of man.
Image of Kumar.
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.